by Media Coverage | Oct 27, 2017 | Blog
Media Coverage FollowFollowFollow NEW YORK (GenomeWeb) – MDx firm Diacarta shared new data today on the use of its colorectal cancer mutation assay in analyzing blood samples of patients with early-stage colorectal cancer, positioning the kit as a liquid biopsy tool....
